The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(((3,5-Dimethylisoxazol-4-yl)methyl)thio)-1-(4-(2-fluorophenyl)piperazin-1-yl)ethan-1-one ID: ALA4513309
PubChem CID: 18106212
Max Phase: Preclinical
Molecular Formula: C18H22FN3O2S
Molecular Weight: 363.46
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: Cc1noc(C)c1CSCC(=O)N1CCN(c2ccccc2F)CC1
Standard InChI: InChI=1S/C18H22FN3O2S/c1-13-15(14(2)24-20-13)11-25-12-18(23)22-9-7-21(8-10-22)17-6-4-3-5-16(17)19/h3-6H,7-12H2,1-2H3
Standard InChI Key: JSXBFJSTDXQCOA-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
7.0770 -10.5588 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3782 -10.9836 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7917 -10.9508 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.4904 -10.5260 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2093 -10.9180 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2254 -11.7349 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.5309 -12.1597 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8119 -11.7677 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9443 -12.1269 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6430 -11.7021 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3780 -12.9110 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9604 -12.9438 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3578 -12.0942 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6793 -13.3358 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6593 -10.5916 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
4.9648 -11.0164 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9458 -10.3768 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.3378 -9.6620 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.1418 -9.8131 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2459 -10.6244 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5063 -10.9722 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3552 -11.7762 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7373 -9.2526 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0567 -9.7419 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.6248 -10.8851 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
3 4 1 0
4 5 1 0
5 6 1 0
6 7 1 0
7 8 1 0
3 8 1 0
9 10 1 0
9 12 2 0
10 13 2 0
11 13 1 0
11 14 2 0
12 14 1 0
6 9 1 0
1 3 1 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
17 21 1 0
21 22 1 0
19 23 1 0
16 20 1 0
15 16 1 0
2 15 1 0
1 24 2 0
10 25 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 363.46Molecular Weight (Monoisotopic): 363.1417AlogP: 3.01#Rotatable Bonds: 5Polar Surface Area: 49.58Molecular Species: NEUTRALHBA: 5HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 1.54CX LogP: 2.23CX LogD: 2.23Aromatic Rings: 2Heavy Atoms: 25QED Weighted: 0.82Np Likeness Score: -2.52
References 1. Johnson JK, Skoda EM, Zhou J, Parrinello E, Wang D, O'Malley K, Eyer BR, Kazancioglu M, Eisermann K, Johnston PA, Nelson JB, Wang Z, Wipf P.. (2016) Small Molecule Antagonists of the Nuclear Androgen Receptor for the Treatment of Castration-Resistant Prostate Cancer., 7 (8): [PMID:27563404 ] [10.1021/acsmedchemlett.6b00186 ]